Biocryst Pharmaceuticals Inc Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -13.45M-33.85M-52.95M-38.33M-35.40M-50.68M
Share-based Compensation 5.53M6.30M4.77M4.17M4.37M10.18M9.71M8.49M12.62M9.40M17.72M14.79M34.64M44.70M55.62M65.41M
Gains from Investment Securities 7.86M8.07M8.99M9.61M10.12M0.34M1.96M4.50M1.13M1.56M2.17M7.54M
Asset Writedowns and Impairment 0.93M1.55M1.35M
Non-cash Items 0.19M0.35M0.56M33.70M
Cash from Operations -16.22M-28.55M-32.25M-37.40M-26.53M-38.55M-13.12M-53.44M-41.14M-92.56M-89.58M-135.11M-142.16M-161.85M-95.14M-52.02M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.15M0.57M0.52M0.16M0.11M0.12M0.12M-0.00M-1.78M-10.26M-11.47M
Amortization of Deferred Charges 0.36M0.44M0.44M0.44M0.44M0.56M0.88M0.89M1.28M2.43M
Depreciation & Amortization (CF) 1.61M2.27M0.89M0.63M0.30M0.18M0.18M0.48M0.70M0.77M0.72M0.75M0.78M1.44M1.66M1.25M
Change in Working Capital
Change in Receivables 21.74M-3.50M-24.40M-1.27M-2.45M7.38M-3.25M2.52M-2.65M-1.82M17.85M-13.90M20.82M21.47M6.09M22.70M
Change in Inventory 6.28M-5.38M-0.64M-0.26M0.68M0.93M-1.11M-0.50M1.65M-1.65M7.04M8.77M12.42M1.45M4.16M
Change in Account Payables -2.05M4.66M13.68M-10.52M3.84M4.49M11.74M17.36M39.41M-22.36M-16.81M-62.38M
Change in Accured Expenses 20.22M-9.48M-10.73M2.07M-2.05M2.16M0.72M2.24M3.10M-0.25M3.06M6.77M4.17M
Other Working Capital Changes -2.56M-2.50M-1.55M-9.58M-1.10M4.43M1.20M-3.70M-1.72M-7.08M1.90M2.14M7.16M2.58M6.82M-1.96M
Investing Activities
Capital Expenditures 0.60M0.33M0.06M0.11M0.03M0.11M5.12M5.28M0.33M0.37M0.34M0.51M2.38M1.35M2.17M1.12M
Sales of Property, Plant and Equipment 0.05M0.00M0.01M
Change in Acquisitions & Divestments 42.44M56.45M56.87M40.83M20.33M34.00M42.41M42.65M43.46M67.75M81.30M43.48M28.20M117.40M385.08M320.48M
Cash from Investing Activities -12.89M0.22M11.32M24.88M-3.47M-39.98M-18.00M23.27M-64.64M4.77M77.93M-6.86M15.80M-128.24M-131.50M52.59M
Financing Activities
Other financing activities -3.48M-1.70M5.18M0.33M0.12M-0.08M11.15M
Cash from Financing Activities 47.90M0.83M23.75M16.96M30.27M111.91M5.48M23.30M135.70M62.50M99.10M300.59M359.67M88.03M32.48M-5.76M
Additional items
Exchange Rate Effect 0.07M0.57M0.36M-0.94M
Change in Cash 18.78M-27.50M2.82M4.45M0.27M33.38M-25.64M-6.86M29.92M-25.29M87.45M158.62M233.39M-201.50M-193.79M-6.12M
Beginning Cash Balance 22.34M41.12M13.62M16.44M20.89M21.16M25.64M6.86M-29.92M25.29M-87.45M-158.62M-233.39M201.50M193.79M6.12M
Free Cash Flow -16.82M-28.88M-32.31M-37.51M-26.56M-38.66M-18.24M-58.72M-41.47M-92.93M-89.93M-135.62M-144.54M-163.20M-97.31M-53.14M
Net Cash Flow 18.78M-27.50M2.82M4.45M0.27M33.38M-25.64M-6.86M29.92M-25.29M87.45M158.62M233.31M-202.06M-194.15M-5.19M